You are on our international English website. This site features our entire product portfolio worldwide. The products featured may not be available in the US. If you are a citizen from the US, please visit your country website for local information and contacts.
Medical Technology for healthcare professionals
Global website (English)
back
Medical Technology
recommended searches
popular searches
Tailoring radiotherapy to the needs of your patient
RADIATION ONCOLOGY

Tailoring radiotherapy to the needs of your patient

Procedure workflows in radiotherapy

ZEISS Ophthalmology cataract Efficiency without compromise
NEURO TUMOR TREATMENTS

Immediate treatment precisely where needed

Neuro tumor treatments are one of the most challenging disciplines. Our ZEISS Tumor Workflow helps you to reconsider the standard of care and supports you with most precise, faster and overall more efficient treatment options than today.

Learn more
ZEISS Ophthalmology cornea refractive Grow your business with one LVC portfolio
BREAST CANCER

Increasing the overall survival for early-stage breast cancer

Intraoperative radiotherapy (IORT) for breast cancer using ZEISS technology enables a precise treatment which can reduce the risk of recurrence, increase the overall survival and reduce side-effects such as pain and cosmesis compared to conventional radiotherapy treatments.1,2,3,4

Learn more
ZEISS Ophthalmology Connecting your procedure workflow
ZEISS Ophthalmology Connecting your procedure workflow

The benefits of intraoperative radiotherapy (IORT) using ZEISS technology

ZEISS Solution for radiotherapy

IORT enables a targeted, risk-adapted and interdisciplinary treatment of various tumors, such as neuro tumors or breast cancer but also other indications. By using low energy x-rays IORT can be given with a high dose, precisely into the tumor or directly after resection to the tumor bed.

ZEISS Intrabeam 600

ZEISS INTRABEAM 600: Melding two worlds into one benefit.

Combining surgery and radiotherapy, ZEISS INTRABEAM 600 enables an individual IORT treatment ensuring that skin and deeper structures are protected and a shorter duration of the radiation therapy compared to external beam radiation therapy (EBRT). This can also reduce associated side effects and enhances treatment comfort for the patient – a key element in increased quality of life.1

Explore clinical peer insights on MyZEISS

Experience sharing in radiation oncology
Peer Insights7 March 2022

Intraoperative radiotherapy after resection of brain metastases – the Stuttgart experience

On-demand webinar - 57 min watch
Oliver Ganslandt, Marc Münter
Peer Insights13 September 2019

Intraoperative Radiation Therapy (IORT): boost during resection of brain metastases

Case - 13 min watch
Stefanie Brehmer, Ahmed-Yasser Abo-Madyan
Peer Insights1 February 2021

Intraoperative radiation therapy during breast-conserving surgery

Case - 5 min watch
Hans-Christian Kolberg

Exclusive content for you and your teams

Gain exclusive learning content, peer-to-peer content, patient material and access to tools to manage your daily tasks.

Explore more

Explore procedure workflow for brain tumor treatment

ZEISS Virtual Experience Showroom
Access virtual showroom
  • 1

    Vaidya, J. S., et al. (2020). Long-term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ, 370, m2836. https://doi.org/10.1136/bmj.m2836
  • 2

    Corica, T., et al. (2018). Cosmetic outcome as rated by patients, doctors, nurses and BCCT. core software assessed over 5 years in a subset of patients in the TARGIT-A Trial. Radiation Oncology (2018) 13:68. https://doi.org/10.1186/s13014-018-0998-x
  • 3

    Keshtgar, M. R., et al. (2013) Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast Cancer Research and Treatment 140, pages 519–525, doi.org/10.1007/s10549-013-2641-8
  • 4

    Welzel, G., et al. (2013) Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiation Oncology Journal 8, 9. doi.org/10.1186/1748-717X-8-9